Jane Street Group LLC Raises Stock Holdings in HUTCHMED (China) Limited (NASDAQ:HCM)

Jane Street Group LLC lifted its stake in shares of HUTCHMED (China) Limited (NASDAQ:HCM) by 362.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 62,997 shares of the company’s stock after acquiring an additional 49,366 shares during the period. Jane Street Group LLC’s holdings in HUTCHMED were worth $1,305,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCM. Rhumbline Advisers grew its stake in HUTCHMED by 8.1% in the 2nd quarter. Rhumbline Advisers now owns 7,553 shares of the company’s stock worth $129,000 after acquiring an additional 564 shares during the period. Renaissance Technologies LLC lifted its stake in shares of HUTCHMED by 74.8% during the 2nd quarter. Renaissance Technologies LLC now owns 131,300 shares of the company’s stock worth $2,248,000 after purchasing an additional 56,200 shares during the period. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of HUTCHMED by 9.7% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 13,216 shares of the company’s stock worth $226,000 after purchasing an additional 1,168 shares during the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of HUTCHMED in the second quarter valued at $213,000. Finally, Point72 Asset Management L.P. acquired a new position in HUTCHMED in the second quarter valued at $279,000. Hedge funds and other institutional investors own 8.82% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com cut shares of HUTCHMED from a “buy” rating to a “hold” rating in a research note on Monday, November 18th.

HUTCHMED Stock Performance

Shares of NASDAQ HCM opened at $14.27 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.68 and a current ratio of 2.81. HUTCHMED has a fifty-two week low of $11.93 and a fifty-two week high of $21.92. The business has a 50 day moving average price of $17.32 and a two-hundred day moving average price of $17.98.

About HUTCHMED

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.